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Abstract
Background: Metastatic malignant melanoma to the liver resulting in fulminant hepatic failure is a
rare occurrence.
Case presentation: A 46 year old man presented to hospital with massive hepatomegaly,
elevated liver enzymes and increased lactate three weeks following resection of a malignant
melanoma from his shoulder (Clark level 5). Initially stable, he decompensated 24 to 48 hours
subsequent to presentation with respiratory failure requiring mechanical ventilation, distributive
shock requiring high dose vasopressor infusion, coagulopathy refractory to plasma infusion,
progressive rise in liver enzymes and severe metabolic abnormalities including hyperkalemia,
acidosis, hyperphosphatemia, hyperuricemia and hypocalcemia. Refractory to aggressive
physiologic support he received palliation. Autopsy revealed >80% liver infiltration by metastatic
malignant melanoma.
Conclusion: We report a case of fulminant hepatic failure secondary to metastatic malignant
melanoma infiltration of the liver.
Background
Malignant melanoma is a common malignancy that has
the potential to metastasize to any site including the liver
[1]. However, liver metastases secondary to melanoma
rarely result in fulminant hepatic failure [2-5] and do not
typically cause significant systemic disease. We cared for a
patient with malignant melanoma who developed fulmi-
nant acute liver failure and multi-system organ failure.
Case presentation
A previously healthy 46-year old man on no medications
was diagnosed with a Clark Level 5 malignant melanoma
on his left shoulder following resection of a mole under
local anesthetic. The lesion was subsequently reported as
a melanoma and three weeks following his resection,
before he could undergo a metastatic work-up, he pre-
sented to hospital with nausea, vomiting and right upper
quadrant pain. He did not appear toxic, he was afebrile,
and physical examination was unremarkable but for a ten-
der right upper quadrant and hepatomegaly. Laboratory
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investigations demonstrated leukocytosis, modestly ele-
vated liver enzymes, and lactic acidosis. Computed tom-
ography scanning revealed marked hepatomegaly with an
extensive infiltrative process and ultrasound demon-
strated normal bile ducts. Baseline imaging of his abdo-
men was planned for staging, however it was not
conducted prior to his presentation to hospital.
On day two of his admission the patient deteriorated with
respiratory failure requiring endotracheal intubation and
mechanical ventilation. He had oliguria, and hypotension
refractory to fluid resuscitation. Rapidly progressive
multi-system organ failure developed with anuria/azo-
temia requiring continuous renal replacement therapy.
Liver failure ensued as evidenced by coagulopathy refrac-
tory to plasma infusions and by progressive transaminitis
and hyperbilirubinema. He developed distributive shock
requiring maximal pressor support. There were significant
biochemical derangements including hyperkalemia, aci-
dosis, hyperphosphatemia, hyperuricemia and hypocal-
cemia. Hemodialysis was commenced to rectify the
hyperkalemia and acidosis that was refractory to continu-
ous renal replacement therapy. An aggressive resuscitative
and treatment approach was undertaken to allow confir-
mation that the liver lesions were melanoma and not a
potentially treatable infection or lymphoma. An ultra-
sound guided transjugular biopsy of the liver was per-
formed in the intensive care unit. Based on a frozen
section diagnosis of malignant infiltration of the liver,
high dose corticosteroid therapy was commenced. The
patient continued to deteriorate despite maximal physio-
logic support and palliative measures were instituted after
discussion with the next-of-kin. He succumbed to his ill-
ness on day-4 of admission. Autopsy revealed >80% liver
infiltration by melanoma (Figure 1), a diagnosis verified
by an immunohistochemical phenotype of S-100 and
HMB-45 positive cells (Figure 2).
Conclusion
Our patient had a rare presentation of metastatic
melanoma to the liver associated with fulminant liver fail-
ure, shock, and multisystem organ failure. Although acute
liver failure has been reported subsequent to infiltration
of the liver by lymphoma [6], breast [7], gastric [8], and
lung cancer [9], there are only rare patients with
melanoma associated with fulminant hepatic failure. We
conducted an English language search of MEDLINE using
the terms hepatic failure and melanoma and only identi-
fied four cases of melanoma associated with liver failure
[2-5]. The natural history of acute liver failure is typically
a rapid progression of liver dysfunction leading to multi-
organ failure and subsequently death. Significant rise in
lactate dehydrogenase was seen in our patient and this has
been previously reported as an ominous sign of acute liver
failure [2,5].
The patient's biochemical derangements of severe hyper-
kalemia, acidosis, hyperphosphatemia, hyperuricemia,
hypocalcemia and markedly elevated lactate dehydroge-
nase most likely represent the natural progression of acute
Liver biopsy contains numerous neoplastic elongate cells  consistent with malignant melanoma infiltration Figure 1
Liver biopsy contains numerous neoplastic elongate cells 
consistent with malignant melanoma infiltration.
Immunohistochemistry of the liver Figure 2
Immunohistochemistry of the liver. S-100 antibody stains 
malignant melanocytes with a brown chromogen (diami-
nobenzidine). Rare negative cells (blue due to hematoxylin 
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liver failure due to massive hepatic necrosis secondary to
tumor burden. However, the patient's biochemical profile
can also be seen in tumor lysis syndrome. Tumor lysis
syndrome has been reported as a complication of malig-
nant melanoma, however in the context of treatment with
chemotherapy [10,11] and corticosteroids [12]. No cases
of tumor lysis syndrome have ever been reported to occur
spontaneously from malignant melanoma infiltration of
the liver. However, spontaneous development of tumor
lysis syndrome in other solid tumors without exposure to
chemotherapy has been reported in the literature [13-15].
Whether the rapid deterioration of the patient was com-
pletely attributable to fulminant hepatic failure or a com-
ponent of tumor lysis syndrome was involved, this case
highlights the potential aggressiveness of malignant
melanoma.
The underlying pathophysiology of the acute liver failure
in our patient was likely secondary to ischemic injury aris-
ing from infiltration of the sinusoids and invasion of
hepatic vessels. Hepatic ischemia has been proposed as
the mechanism by which lymphoma may cause fulmi-
nant hepatic failure [16,17] and is supported by the
marked rise in aspartate aminotransferase and lactate
dehydrogenase seen in our patient.
In summary, we report an unusual case of fulminant
hepatic failure associated with multisystem organ failure
resulting from metastatic melanoma replacing the vast
majority of the liver. Although rare, our case would por-
tend that malignant melanoma metastasizing to the liver
can cause fulminant hepatic failure. Thus, in patients with
a history of malignancy who present in acute liver failure
clinical suspicion for malignant infiltration of the liver
should be considered and ruled out before referral for
consideration for liver transplantation.
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